Stockwinners Market Radar for November 19, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:01 EST Cheniere Energy CEO buys 8.4K shares of common stock - In a regulatory filing, Cheniere Energy disclosed that its CEO Jack Fusco bought 8.4K shares of common stock on November 19th. The total transaction size was $503K.

18:56 EST Fly Intel: After Hours Movers - UP AFTER EARNINGS: Avid Technology (AVID) up 15.9% after above-consensus initial guidance for FY20... China Distance Education (DL) up 6.7%... Esco Technologies (ESE) up 1.6%. ALSO HIGHER: BioCryst (BCRX) up 6.2% after disclosing Point72 passive stake CytomX (CTMX) up 3.5% after being initiated with Buy at Guggenheim... Endo International (ENDP) up 4.3% after FDA accepted BLA application for CCH... Avaya Holdings (AVYA) up 3.1% after announcing management changes... Baker Hughes (BKR) up 2.0% after being initiated with Buy at Deutsche Bank... DOWN AFTER EARNINGS: Urban Outfitters (URBN) down 14.7%... Alcon (ALC) down 1.7%. ALSO LOWER: Organogenesis (ORGO) down 8.9% after equity offering... Amarin (AMRN) down 6.2% after being initiated with Underperform at Oppenheimer... CRISPR Therapeutics (CRSP) down 5.0% after equity offering... MGM Growth Properties (MGP) down 3.6% after equity offering... Transocean (RIG) down 2.4% after being initiated with Sell at Deutsche Bank... New York Mortgage Trust (NYMT) down 2.4% after equity offering... Middlesex Water Co (MSEX) down 2.1% after equity offering. Movers as of 18:30ET.

18:45 EST Nvidia CEO: We're at the beginning of the artificial intelligence revolution - In an interview on CNBC's Mad Money, Nvidia (NVDA) CEO Jensen Huang said: Every industry will be revolutionized by AI... We came roaring back this last quarter all because of AI... We create computer technology that makes it possible to do things that would otherwise be impossible... We now have computers than can learn by themselves... We've created the ability for computers to understand the "code" of human knowledge... Regulatory discussions for the Mellanox (MLNX) merger are "going fine."

18:24 EST Royal Gold raises quarterly dividend to 28c from 26.5c per share - The dividend is payable on January 17, 2020 to shareholders of record at the close of business on January 3, 2020.

18:18 EST Walmart EVP Furner sells 8.3K shares of common stock - In a regulatory filing, Walmart disclosed that its EVP Judith McKenna sold 8.3K shares of common stock on November 15th. The total transaction size was $989.4K.

18:01 EST Sysco appoints Michael Foster as Chief Information and Technology Officer - Sysco announced that Michael Foster will join the company as Chief Information and Technology Officer, effective December 2. He will serve as Sysco's senior technology leader with responsibility for all aspects of our global technology agenda, and will partner with other Sysco leaders in helping to shape the company's broader strategic direction and future growth agenda. Prior to joining Sysco, Mr. Foster was executive vice president and chief information officer for CN Railway, where he was responsible for information technology, operational technology and information security. Prior to joining CN Railway, he spent more than 20 years at Federal Express in various technology leadership and executive roles across multiple global subsidiaries.

17:59 EST Plains GP Holdings director Everardo Goyanes buys over $358K in company shares - Plains GP Holdings director Everardo Goyanes disclosed in a regulatory filing that he had purchased 20,000 shares of company stock at $17.91 per share on November 18. The total transaction value of the purchase was $358,294.

17:34 EST Retail Properties of America says Shake Shack is 1st signed lease at Circle East - Retail Properties of America (RPAI) announced that Shake Shack (SHAK) has signed a new lease at its Circle East redevelopment project located in Towson, MD. Shake Shack will be located in a 3,200 square foot space on Circle East's prominent corner, on Joppa Road at the circle interchange in downtown Towson. "We are excited to add the first Shake Shack to the Baltimore suburbs and believe that the addition of an industry-leading quick service restaurant will be in demand by a market that is comprised of young, affluent and educated shoppers who seek the 'live, work, play' environment that Circle East will deliver," stated Greg Goldberg, vice president, leasing director - eastern division. "Circle East is poised to become a walkable, active environment with a sought-after lineup of brands, and we continue to attract both national and local retailers, services, and restaurants that are unique to the market and will deliver a true 'main street' to Towson."

17:25 EST Boeing awarded maximum $232M Defense Logistics Agency delivery order - Boeing has been awarded a maximum $232M firm-fixed-price delivery order against a five-year basic ordering agreement for the AH64 CH47 global material support program. This was a sole-source acquisition using justification 10 U.S. Code 2304, as stated in Federal Acquisition Regulation 6.302-1. This is a five-year base contract with one four-year option period. Locations of performance are Missouri and Arizona, with a November 18, 2024 performance completion date. Using military service is Army. Type of appropriation is FY20 through FY24 defense working capital funds. The contracting activity is the Defense Logistics Agency Aviation.

17:01 EST TimkenSteel to close its Houston Material Services facility - TimkenSteel announced plans to close its TimkenSteel Material Services facility in Houston, Texas, in the first quarter of 2020. The 100,000-square-foot operation currently employs approximately 100 people who provide precision and finishing services, primarily to customers in the energy market. As a result of the plant closure, the company expects to realize approximately $6M-$8M of annual savings.

16:52 EST BioCryst up over 10% at $2.24 per share after disclosing Point72 passive stake

16:48 EST Univar signs 10-year contract extension with Boeing South Carolina - Univar Solutions (UNVR) announced that its Onsite Services,OSS, contract with Boeing (BA) South Carolina has been extended for 10 years. The Univar Solutions' OSS team began providing waste and environmental services at Boeing South Carolina in 2014, including maintaining and improving Boeing's Zero Waste to Landfill initiative. The team has contributed to Boeing's policy of environmental stewardship by partnering with small and local businesses to identify and develop unique alternatives for waste, such as the reutilization of large component boxes, which can be converted into tiny homes and storage solutions. During the past five years, the OSS team at Boeing has successfully identified a multitude of opportunities for increased efficiency and improved processes, initiating a number of projects that have resulted in improved sustainability for Boeing. "This opportunity to continue our strong partnership with Boeing South Carolina means expanding the market-leading world-class waste and recycling program our teams have built together. We are proud to work with an organization which is so committed to environmental responsibility, and look forward to developing more sustainable solutions that benefit our partners at Boeing, our local South Carolina communities, and the environment," said Ryan Kennebeck, Univar Solutions site manager, Boeing South Carolina.

16:43 EST Venus Concept receives Health Canada OK to market Venus Bliss in Canada - Venus Concept announced that it has received a medical device license issued by Health Canada to market Venus Bliss, a medical aesthetic platform that offers a comprehensive solution to fat reduction and cellulite reduction, with two technologies in one platform. It is intended for use in non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index of 30 or less, and is also indicated for use in temporary skin tightening, circumferential reduction, and cellulite reduction. Venus Bliss is a non-invasive medical aesthetic device that offers a comprehensive solution with two technologies in one system. The 1064 nm diode laser applicators are used to treat focal fat in the abdomen and flanks through non-invasive lipolysis, resulting in fat reduction. To complete the treatment and achieve a more contoured appearance, the (MP)2 applicator is used to tighten lax skin and reduce circumference. It uses our proprietary (MP)2 technology which combines Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields with advanced VariPulse technology. The (MP)2 applicator also reduces the appearance of cellulite - another popular treatment that providers can offer to their patients.

16:43 EST SUMR Brands announces CEO Mark Messner to step down - SUMR Brands announced that Mark Messner will be stepping down as the company's CEO to pursue other opportunities and spend time with his family. The Board of Directors has begun a search for an interim CEO to replace Messner, who will remain in his role to assist in the transition until December 13, 2019 or such earlier date that his successor is appointed.

16:41 EST BioDelivery Sciences director sells 200K shares of common stock - In a regulatory filing, BioDelivery Sciences disclosed that its director Todd Davis sold 200K shares of common stock on November 15th. The total transaction size was $1.22M.

16:38 EST Comfort Systems USA authorizes additional buyback of 764.8K shares of stock - Comfort Systems USA announced that its board has approved an amendment to the company's stock repurchase program to increase the shares authorized and remaining as available to purchase back up to 1,000,000 shares by authorizing the company to acquire up to 764,760 additional shares of its outstanding common stock. The company's existing stock repurchase program had previously authorized the repurchase of up to 8,783,409 shares of the company's outstanding common stock.

16:33 EST Leidos names Sanjay Parthasarathy as business development and strategy VP - Leidos announced that Dr. Sanjay Parthasarathy has been named vice president, business development and strategy, for Leidos Defense Group's Logistics and Mission Support Operation.

16:32 EST NXP Semiconductors announces 37.5c interim dividend for Q4 - NXP Semiconductors announced that, as part of the Quarterly Dividend Program, its board of directors has approved the payment of an interim dividend for the Q4 of 37.5c per ordinary share. The interim dividend will be paid on January 6, 2020 to shareholders of record as of December 16.

16:18 EST Avid Technology sees FY20 adjusted EBITDA $66M-$74M - Sees FY20 free cash flow $27M-$35M.

16:17 EST Fluent announces $5M shares repurchase program - Fluent announced that its Board of Directors approved a stock repurchase program. The program authorizes the repurchase of up to $5M of shares of the Company's common stock. The repurchases will be made from time to time in open market transactions at prevailing market prices or in negotiated transactions off the market.

16:16 EST Wins Finance receives listing qualifications letters from Nasdaq - Wins Finance Holdings announced that on November 18, 2019, the company received a notification letter from the NASDAQ Listing Qualificatio stating the company was not in compliance with NASDAQ Listing Rule 5250c1, due to its failure to timely file its Annual Report on Form 20-F for the year ended June 30, 2019. The NASDAQ notification letter provides the company 60 calendar days from the date of the notification, or until January 17, 2020, to submit a plan to NASDAQ to regain compliance with the NASDAQ's continued listing requirements. If the plan is accepted, NASDAQ can grant an exception of up to 180 calendar days, or until May 13, 2020, for the Company to regain compliance. The company may regain compliance at any time by filing its 2019 20-F. If NASDAQ does not accept the company's compliance plan, the company will have the opportunity to appeal that decision to a Hearing Panel under Listing Rule 5815a. The NASDAQ notification letter has no immediate effect on the listing of the company's common stock on the NASDAQ Capital Market. The company intends to provide a plan of compliance to the NASDAQ Staff on or before January 17, 2020.

16:13 EST Akcea Therapeutics announces closing of licensing agreement with Pfizer - Akcea Therapeutics (AKCA), a majority-owned affiliate of Ionis Pharmaceuticals (IONS), announced the closing of the exclusive licensing agreement with Pfizer (PFE) for AKCEA-ANGPTL3-LRx following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. AKCEA-ANGPTL3-LRx is an investigational antisense therapy discovered by Ionis and being developed to treat patients with certain cardiovascular and metabolic diseases. As previously announced, under terms of the agreement Akcea and Ionis will receive a $250M upfront license fee, which will be split equally between the two companies. Akcea will settle its $125M obligation to Ionis in Akcea common stock.

16:10 EST Cannae Holdings names Richard Massey as new CEO - Cannae Holding announced the board of directors has appointed Richard N. Massey as CEO effective November 15, 2019. In addition to the role of Chief Executive Officer, Mr. Massey will remain on the board of directors of Cannae and as Senior Managing Director of Trasimene Capital Management, LLC. Mr. Massey was most recently as a partner of Westrock Capital Partners and Bear State Advisors, both multifamily investment offices.

16:06 EST New Media, Gannett complete merger - New Media Investment Group Inc. (NEWM) and Gannett Co., Inc. (GCI) jointly announced the successful completion of the previously announced acquisition of Gannett by New Media for a combination of cash and stock. As previously announced, Gannett stockholders are entitled to receive $6.25 in cash and 0.5427 shares of New Media common stock per share of Gannett common stock in the Merger. The combined company will operate under the name "Gannett Co., Inc.". Beginning on November 20, 2019, New Media will trade on the New York Stock Exchange under this name and its ticker symbol will be changed to "GCI". Michael Reed will remain Chairman and Chief Executive Officer of the combined company and Paul Bascobert will serve as Chief Executive Officer of the operating subsidiary, Gannett Media Corp.

16:05 EST iRhythm receives Nasdaq deficiency notice due to delayed quarterly report - iRhythm Technologies announced that it received a standard notification letter from The Nasdaq Stock Market , dated November 14, stating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2019, iRhythm is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission.This Notice has no immediate effect on the listing of iRhythm's common stock.

16:03 EST First Bancorp raises dividend 50%, announces $40M share repurchase program - The Board of Directors of First Bancorp has declared a cash dividend on its common stock of 18c per share payable on January 24, 2020 to shareholders of record as of December 31, 2019. The 18c dividend rate represents a 50% increase over the prior dividend rate of 12c. Additionally, the Board of Directors has authorized an updated share repurchase program, pursuant to which the company may purchase shares of its common stock for an aggregate repurchase price not to exceed $40M. The initial expiration of the Share Repurchase Program is set for December 31, 2020. The Share Repurchase Program does not obligate the Company to purchase any shares. The authorization for the Share Repurchase Program may be terminated by the Company's Board of Directors at any time. The Share Repurchase Program replaces a similar program announced on February 5, 2019 that provided up to $25M of repurchase authorization. The company repurchased shares with a total price of $10M under that program.

15:36 EST Berry Petroleum says CA moratorium to have no impact on 2019 performance

15:20 EST Microsoft's Mixer says Partners now can gate ability to clip streams - Microsoft's (MSFT) Mixer said that, starting today, Mixer Partners will be able to expand clip creation access to all viewers or gate the ability to clip behind a specific channel progression rank. For example, a Partner can now customize their channel to only enable community members at rank 30 or above to clip, ensuring that only more regular viewers can clip in their specific channel. "Another piece of feedback we've gotten is you want more control over editing clips," the company said. "Beginning today, when a viewer starts to create a clip on the web, they will be able to trim to a specific section and preview the clip before publishing. Clips can be trimmed to a minimum of 15 seconds and a maximum of 60s. This will enable creators to generate higher quality clips that focus right on the action without the guesswork." The Fly notes that this news comes after several top video game streamers this year, such as Tyler "Ninja" Blevins, have moved away from Amazon's (AMZN) Twitch to stream exclusively on Mixer. Reference Link

14:21 EST Facebook says F8 conference to take place May 5-6 - Facebook announced that its 2020 F8 annual developer conference will take place on May 5-6 at the McEnery Convention Center in San Jose, California. Reference Link

14:05 EST Arbor Realty launches proprietary single-family rental portfolio platform - Arbor Realty Trust announces the launch of its proprietary Single-Family Rental, SFR, portfolio lending platform. Single-family rentals comprise a significant portion of overall U.S. apartment inventory, accounting for more than half of the nation's nearly 43.4 million rental units. Since the Great Recession, this sector has continued to expand its market share of the overall housing market, becoming the fastest-growing segment of occupied rental households. "We believe the single-family rental portfolio market, which is currently very fragmented, is as big as the multifamily market, with unique financing opportunities available in build-to-rent, bridge and permanent lending products," said Ivan Kaufman, President and CEO, Arbor Realty Trust. "By bringing capital to this business, we can leverage our national, tenured originations team and our more than 30 years of experience in residential and multifamily housing to become a leader in this space."

13:14 EST Abiomed says AHA analysis of Impella 'flawed' - The Abiomed medical office is issuing a publication review of the observational analysis of Impella that was presented by Amin et al. at the American Heart Association Conference on November 17, stating in a related press release that "the AHA analysis is flawed because: The data source has significant limitations, containing just a fraction of Impella patients and unable to delineate between common adverse events; The Impella patients were much sicker and had greater baseline and procedural risks; The analysis excluded the costliest IABP patients who were escalated to other therapies Additionally, the conclusion is aggressive because administrative coding data cannot delineate between adverse events common to high-risk patients and device related events. A video summarizing the review's findings was also posted by the company on the site ProtectedPCI.com. Reference Link

13:06 EST General Cannabis to sell Greenhouse Office building for approx. $1.7M - General Cannabis Corp. announced it has entered into a contract for the sale of its Greenhouse Office building in Denver, Colorado for $1,697,500. General Cannabis acquired the property in 2014 for $1.05M. The closing is subject to customary conditions.

12:44 EST Merck boosts quarterly dividend to 61c from 55c - Merck announced that its board has declared a quarterly dividend of 61c per share of the company's common stock for Q1 of 2020. Payment will be made on Jan. 8, 2020 to shareholders of record at the close of business on Dec. 16, 2019.

12:06 EST Novartis granted orphan status for PIK3CA-related overgrowth spectrum - The FDA granted Novartis orphan status for alpelisib, its treatment of PIK3CA-related overgrowth spectrum. Reference Link

12:00 EST Kohl's falls -17.7% - Kohl's is down -17.7%, or -$10.34 to $48.06.

12:00 EST 58.com rises 13.0% - 58.com is up 13.0%, or $6.51 to $56.76.

12:00 EST Nesco Holdings rises 18.6% - Nesco Holdings is up 18.6%, or 66c to $4.20.

11:36 EST Spotify launches 'Your Daily Podcast playlist' - In an earlier blog posting music streaming firm Spotify said in part: "You've just binged your favorite podcast and you're finally caught up. But now you have to wait an entire week until the next episode. Now what? Now we've created Your Daily Podcasts-our first daily personalized podcast playlist that gives users an easy way to discover new shows while also keeping up with old favorites. If you've listened to at least four podcasts in the past 90 days, you'll find the playlist in the "Your Top Podcasts" shelf on Home or in the "Made For You" hub on browse." Reference Link

11:17 EST Genmab announces European marketing authorization for DARZALEX combination - Genmab announced that the European Commission has granted marketing authorization for DARZALEX in combination with lenalidomide and dexamethasone as treatment for adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. The EC approval follows a positive opinion issued for DARZALEX by the CHMP of the European Medicines Agency in October 2019. In August 2012, Genmab granted Janssen Biotech, (JNJ) an exclusive worldwide license to develop, manufacture and commercialize daratumumab. The approval was based on data from the Phase III MAIA study of daratumumab in combination with Rd as treatment for patients with newly diagnosed multiple myeloma, who are not candidates for high dose chemotherapy and ASCT.

11:13 EST TJX 'confident' in gaining share globally in Q4 and on - Comments provided during Q3 earnings conference call.

10:48 EST Wayfair shares down 2% to $84.81, Citron says going to $45 short term

10:22 EST Karuna Therapeutics Inc trading resumes

10:17 EST Karuna Therapeutics Inc trading halted, volatility trading pause

10:08 EST Stilwell Group urges Wheeler REIT shareholders to vote for director nominees - The Stilwell Group, the largest shareholder of Wheeler Real Estate Investment Trust, announced that it delivered the following open letters to shareholders of the Company. The first letter from Megan Parisi read, in part, "Wheeler continues trying to distract you from the real issue plaguing the Company, which is their persistent failure to manage the Company in the owners' best interest. This election is about the need for change at WHLR. As promised, Dave Kelly has stooped to mudslinging and subterfuge out of desperation to keep his compensation and position rather than face his failures. We've been trying to find out more about the 'Sea Turtle Marketplace Project' for some time. WHLR lost (promptly) $12 million of Company money on the then CEO's outside project. All of the legacy directors approved this disaster. Did any of these legacy directors have a personal interest in Sea Turtle? Did any of them have a more involved role in this fiasco? We hear Dave Kelly gets very nervous when the topic of Sea Turtle comes up. They've been fighting desperately to keep this and other information from us. And who keeps stealing the sign we installed on Virginia Beach Boulevard? Trespassing and theft are criminal offenses." The second letter from Joseph Stilwell read, in part, "One of my children is, mercifully, recovering from a near-fatal illness. I will not join in slander or scandal - neither responding to nor commenting on what is aimed at me, nor will I direct slander or scandal toward others. If WHLR shareholders elect me and our other nominees as directors, we will work diligently to restore and then create shareholder value in a professional and businesslike manner.

10:00 EST Kohl's falls -15.2% - Kohl's is down -15.2%, or -$8.89 to $49.51.

10:00 EST Amneal Pharmaceuticals rises 8.8% - Amneal Pharmaceuticals is up 8.8%, or 25c to $3.08.

10:00 EST Myovant Sciences rises 127.5% - Myovant Sciences is up 127.5%, or $7.73 to $13.79.

09:47 EST DHT Holdings falls -7.6% - DHT Holdings is down -7.6%, or -57c to $6.95.

09:47 EST Intelsat falls -17.2% - Intelsat is down -17.2%, or -$1.38 to $6.65.

09:47 EST 58.com rises 9.9% - 58.com is up 9.9%, or $4.96 to $55.21.

09:35 EST Qualcomm sees 3-year QCT SAM revenue growth at 10% CAGR - Expects QCT to grow faster than SAM and Apple product revenues from FY20-FY22. Sees 3-year QCT operating margin greater than20%, with QTL operating margin approximately 70%. Sees 3-year tax rate 14%. Comments taken from company presentation slides.

09:32 EST Citi introdues high-yield digital checking account with no ATM fees nationwide - Citibank announced that it is introducing Citi Elevate Checking, a high-yield checking account that offers unlimited ATM reimbursements nationwide while paying interest up to 1% for U.S. customers residing outside of the bank's physical branch footprint. "With ATM fees climbing to record levels, we saw an opportunity to provide customers with two very useful benefits - no ATM fees and an interest rate that's up to 12 times the national average," said Harp Rana, Head of U.S. Deposit Products, Citibank.

09:30 EST Autoliv expects to grow sales by 3%-4% in the medium term - Autoliv will hold a Capital Markets Day today in Utah, USA. During the Capital Markets Day members of Autoliv management will outline the company's strategy, operational strengths, growth opportunities, innovation roadmaps, financial plans and targets. For the first 10 months of 2019, Autoliv estimates its global share of orders was around 50%. From this strong foundation, Autoliv will broaden its mission to safety for mobility and society while transforming its operations for the new age of digitalization and automation throughout the whole value chain. During the capital markets day, Autoliv will update and outline its targets and ambitions. On average the company expects to grow sales in the medium term organically by 3-4% more per year than light vehicle production growth and the company aim to improve its adjusted operating margin to around 12%, based on an assumed average light vehicle production growth of 1-2% per year. Autoliv aim for a cash conversion of at least 80%. The company maintains its target for leverage ratio of around 1x, with a range of 0.5x to1.5x. In the long term the company expects to grow at least in line with our market. When the ongoing and planned strategic initiatives are fully implemented, the ambition is to further increase earnings capacity, to an adjusted operating margin of around 13%.

09:24 EST Ferroglobe receives Nasdaq letter regarding non-compliance - Ferroglobe announced that it has received a notification letter from the Listing Qualifications Department of the NASDAQ Stock Exchange, notifying the Company that the minimum bid price for its ordinary shares has been below $1.00 for a period of 30 consecutive trading days and the Company therefore no longer meets the minimum bid price requirement of NASDAQ listing rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's ordinary shares on NASDAQ. Under the NASDAQ listing rules, the Company has until May 18, 2020 to become compliant with the Minimum Bid Requirement. If the closing bid price of the Company's ordinary shares is at least $1 for a minimum of 10 consecutive business days during the period to May 18, 2020, NASDAQ will provide written confirmation of compliance with the Minimum Bid Requirement and the matter will be closed. If the Company does not regain compliance by May 18, 2020, the Company may be eligible for an additional period of 180 days during which to achieve compliance, provided that the Company otherwise meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for NASDAQ other than the Minimum Bid Requirement and provides written notice of its intention to remedy the non-compliance during this second compliance period, by effecting a reverse stock split if necessary. NASDAQ has the right not to grant the additional cure period if it appears to it that the Company will not be able to cure the deficiency or is not otherwise eligible. The Company intends to continue actively to monitor the bid price for its ordinary shares throughout the period to May 18, 2020 and to take appropriate measures to remedy the deficiency and regain compliance with the Minimum Bid Requirement.

09:17 EST Kohl's sees FY19 gross margin down 60-65bps

09:17 EST Kohl's sees FY19 comp sales down 1.5% to down 1%

09:15 EST Dasan Zhone selected by Rakuten Mobile for 5G fronthaul solutions - DASAN Zhone Solutions announced it has been selected by Rakuten Mobile as a technology partner to deliver the next generation of mobile cell site aggregation switches that support 4G LTE & 5G ready services as well as Wi-Fi services.

09:14 EST Home Depot says all U.S. divisions posted positive comps in Q3 - Says: We continue to see strong and engaged customer... Pro sales outpaced DIY sales in U.S... Unwinding complex legacy IT systems proving to be more complicated than anticipated... Seeing healthy growth in online sales... Customer service scores have increased y/y... Saw solid performance in big ticket transactions... Tariffs created increased costs in Q3... Continue to believe we can effectively mitigate tariffs. Comments taken from Q3 earnings conference call.

09:10 EST Neovasc announces highlighting of Tiara System at PCR London Valves meeting - Neovasc announced that its transfemoral trans-septal Tiara System was featured today in a tutorial session at the PCR London Valves 2019 meeting, which is taking place November 17-19 in London. Anson Cheung, MD, Clinical Professor of Surgery and Director of Cardiac Transplant of British Columbia, and Principal Investigator for the Tiara Early Feasibility Study at St. Paul's Hospital, Vancouver, BC, provided an update on the Tiara program as part of "Rapid fire - Latest updates from the world of TMVR," a session focusing on early clinical outcomes of patients undergoing transcatheter mitral valve replacement and potential future device solutions. The TF/TS Tiara system builds on the continuing success of the transapical Tiara system. Outcome data was presented on 71 of the 80 high surgical risk patients who have been treated with TA Tiara in either the TIARA-I Early Feasibility Clinical Study, Compassionate Use cases, or the TIARA-II CE Mark Clinical Study. The data included the 30-day survival rate for patients implanted with TA Tiara of 89%, with one patient now having survived over five and a half years post implant. The procedural success rate was 94%, with 0% procedural mortality reported. Resolution of mitral regurgitation was observed in a majority of cases, with MR being none to trace in 88% of patients at discharge.

09:08 EST Autoliv updates medium-term, long-term targets at capital markets day - Autoliv announced it will hold a Capital Markets Day during which members of Autoliv management will outline the company's strategy, operational strengths, growth opportunities, innovation roadmaps, financial plans and targets. For the first 10 months of 2019, Autoliv estimates its global share of orders was around 50%. "From this strong foundation, Autoliv will broaden its mission to safety for mobility and society while transforming its operations for the new age of digitalization and automation throughout the whole value chain. This includes execution of structural efficiency programs, enhancing automation programs, and execute end-to-end value chain improvement programs," the company said. In terms of medium-term, or up to 3-5 years, targets, the company said on average it sees to grow sales organically by 3-4% more per year than light vehicle production growth and the company aim to improve its adjusted operating margin to around 12%, based on an assumed average light vehicle production growth of 1-2% per year. Autoliv aims for a cash conversion of at least 80%. The company maintains its target for leverage ratio of around 1x, with a range of 0.5x to1.5x. For the long-term, or beyond 5 years, "Our ambition remains to grow at least in line with our market. When our ongoing and planned strategic initiatives are fully implemented, the ambition is to further increase our earnings capacity, to an adjusted operating margin* of around 13%," Autoliv stated. The company added regarding 2020: "Looking into next year, we see potential tailwinds and headwinds. Potential tailwinds include raw material costs, organic growth from market share gains, positive impacts from ongoing cost reduction programs and a stabilization of light vehicle production. Potential headwinds include lower inflator replacement sales and higher depreciation and amortization. Considering these potential tailwinds and headwinds we expect a year over year improvement in adjusted operating margin, absent unforeseen events."

09:05 EST KAUST installs Cray CS-Storm 500NX supercomputer for AI initiative - Cray (CRAY), a Hewlett Packard Enterprise (HPE) company, announced that the King Abdullah University of Science and Technology in Saudi Arabia has selected a Cray CS-Storm 500NX supercomputer to support innovation in the university and the nation through a strategic artificial intelligence initiative. The added power of the GPU-accelerated CS-Storm system provides KAUST researchers greater computational capabilities to drive positive and significant outcomes in the university's core research areas of global significance: food, water, energy, the environment, and digitalization.

09:02 EST Apex Global Brands announces launch of HI-TEC Lifestyle in North America - Apex Global Brands has officially announced that HI-TEC Lifestyle has made its North American debut exclusively through Urban Outfitters. Following a successful European launch, the heritage-meets-streetwear inspired clothing line is being sold exclusively online and in the US-based retailer's Herald Square location in New York City as of November 2019. The unisex capsule collection features nine pieces of apparel from the HI-TEC Lifestyle line, including t-shirts, long sleeve shirts, pants and sweaters.

08:57 EST ConocoPhillips outlines 10-year plan at analyst and investor meeting - ConocoPhillips is hosting an analyst and investor meeting to reaffirm its commitment to the returns-focused strategy it launched in 2016. The company will outline the details of a 2020-2029 operating and financial plan, and will provide region and asset reviews of its global portfolio. Highlights of the 10-year plan include: Free cash flow of approximately $50B based on a real West Texas Intermediate price of $50 per barrel and annual capital expenditures averaging less than $7B over the decade; A capital expenditures plan that reflects optimized pace of development within each asset, low capital intensity and overall low-declining base production; Currently announced and planned dispositions, as well as a future 25% dilution of company-operated Alaska assets consistent with the company's historical practice of not funding major-project expenditures at 100%; Resource base of approximately 15B barrels of oil equivalent at less than $40 per barrel WTI average cost of supply; Forecast underlying compound annual production growth averaging over 3%; Projected ordinary dividends of approximately $20B, reflecting growth in the current dividend over the plan period; Projected $30B in share buybacks over the 10-year period, representing almost 50% of current market capitalization; Planned dividends and repurchases funded from free cash flow over life of the plan, representing a combined annual shareholder payout that exceeds our distribution target of more than 30% of cash from operations; Expected growth in return on capital employed of 1-2 percentage points annually and continued balance sheet strength with an expected leverage ratio of net debt to cash from operations of less than one.

08:42 EST Weyland Tech CEO Brent Suen purchases 900,000 shares of company stock - Weyland Tech reported that its president and CEO, Brent Suen, purchased 900,000 shares of Weyland common stock from a private investor at an average price of $0.35 per share. The transaction was reported to the U.S. Securities and Exchange Commission on Form 4. In October, Suen purchased from the open market 99,000 shares of the company common stock, which was also reported on Form 4. Suen now holds 2,832,000 shares of Weyland stock. Pursuant to Weyland Tech's insider trading rules, company insiders who purchase the company's common stock from any source are required to hold it for a minimum of two years. The company is preparing for an uplist to the Nasdaq Stock Market, where it expects to attract the attention of a broader base of investors, particularly institutional and family offices.

08:39 EST Iteris awarded traffic signal synchronization project by Rancho Cucamonga - Iteris announced that it has been awarded a traffic signal synchronization project by the City of Rancho Cucamonga. The three-year project includes signal coordination and timing improvements at two major corridors in the southern California city, with the aim of improving traffic flow, enhancing public safety and decreasing stops. Under the project agreement, Iteris will provide services that will update coordination timing plans, prepare plans for the design of traffic signal modification and interconnect system upgrades, and provide construction support and installation services as well as training opportunities to City of Rancho Cucamonga staff. The primary goal of this project is to deploy new intelligent transportation system communication infrastructure to support the management of the city's transportation network, implement optimized coordination timing plans to achieve optimal traffic flow and improve safety for all road users, including vehicles, buses, bicycles and pedestrians.

08:37 EST B.O.S. Better Online receives $400,000 robotic system order - B.O.S. Better Online Solutions announced that it has received a $460,000 order from a Mexican plastic manufacturer. The order is for a robotic system of In-Mold Labeling for injection molding products, and is expected to be delivered by the second quarter of 2020.

08:35 EST VERB Technology announces partnership with NCompassTrac - VERB Technology Company announces a new partnership with NCompassTrac, a company focused on the development of cloud and mobile-based technologies that enhance and increase the revenue potential of Automotive and PowerSports dealers throughout the world. VERB's partnership with NCompassTrac is part of a new initiative called the CustomerTrac Marketplace in which NCompassTrac is teaming up with leaders in the Automotive and PowerSports industries to create a marketplace that allows Dealers to discover the best revenue opportunities and take action fast. By offering VERB's interactive video capabilities within their CustomerTrac Marketplace, dealerships can communicate more effectively with their customers and increase overall growth and retention with no change to their DMS. With this new initiative, among others, NCompassTrac expects to double their client base in 2020.

08:34 EST Drinkworks, Brown-Forman announce partnership for co-branded cocktails - Drinkworks, a joint venture between Keurig Dr Pepper (KDP) and Anheuser-Busch InBev (BUD), and spirits and wine company Brown-Forman Corporation (BFA, BFB) announced a partnership to develop signature cocktails for use in the Drinkworks Home Bar system. With the Brown-Forman and Drinkworks partnership, consumers will be able to enjoy their favorite cocktails made with their favorite brands. The initial selection is expected to hit the market in mid-2020. The new co-branded cocktails will be produced by Drinkworks and available on drinkworks.com. The initial menu of signature cocktails will likely feature several Brown-Forman spirits, such as Jack Daniel's, Gentleman Jack, Herradura and Chambord, and include classic cocktails like Margaritas and Manhattans as well as more adventurous cocktails like French Martinis.

08:31 EST NanoVibronix provides business update for Q3 - NanoVibronix provided a business update for Q3. "This has been a productive and important quarter for NanoVibronix, positioning us for accelerating growth in 2020 and beyond," commented Brian Murphy, CEO of NanoVibronix. "In the past few quarters, we have significantly expanded our manufacturing capabilities, growing capacity from approximately 100 per month to, initially, over 1,000 per month with the ability to grow. Simultaneously, we have broadened our distribution channels, adding key partners to directly target key potential customers, including the Federal Supply Schedule and CMS/Medicare, and we are making progress in our efforts to target the Veterans Administration and European customers through private label arrangements. We believe that we have the optimal team in place to deliver. We enter the Q4 in the best strategic position in our company's history, and I am excited about the opportunities in front of us. Our new Chinese manufacturer has finished first products on November 15th, and should have 3,000 units completed by early January. Our current pipeline, including back orders, and fulfilling our first private label order, will consume the majority of our initial production. Our new licensing arrangement with Medisana is progressing as planned, and this manufacturing capability enables us to support Medisana's growth. Other potential partners are in various stages of discover, clinical testing, and market testing, which we feel very comfortable about."

08:15 EST Synchronoss and Accruent announce partnership - Accruent and Synchronoss Technologies have announced a partnership that will combine the Synchronoss Insights Platform with Accruent's vx Observe IoT asset monitoring software. The collaboration will deliver valuable insights and efficiencies to enterprises across facilities and greatly expand the effectiveness of enterprise IoT solutions.

08:11 EST Golden Nugget launches Everi's gaming content in New Jersey - Everi Holdings announced that GoldenNuggetCasino.com has exclusively launched the Company's player-favorite Triple Threat and six other titles for online real-money play in New Jersey. GoldenNuggetCasino.com is now fully integrated with Everi's Remote Game Server, providing Golden Nugget with direct access to the Company's premium land-based titles for its iGaming platform, including additional titles expected to follow the exclusive launch.

08:07 EST HTG Molecular releases HTG EdgeSeq Reveal software version 2.0.0 - HTG Molecular Diagnostics announced the release of its HTG EdgeSeq Reveal data analysis software, version 2.0.0. HTG EdgeSeq Reveal is a powerful software product that streamlines sample analysis using the HTG EdgeSeq platform. The new software contains enhanced functionality enabling rapid data analysis from the HTG EdgeSeq miRNA Whole Transcriptome Assay and the newly released HTG EdgeSeq Autoimmune Panel. Together with the company's other research use only molecular profiling assays, we expect that customers using the new HTG EdgeSeq Reveal software product will be able to draw conclusions and generate charts from their data more quickly and seamlessly.

08:05 EST Gogo's 2Ku high-speed inflight connectivity solution selected by Qatar Airways - Gogo announced that it has been selected by Qatar Airways to install the Gogo 2Ku high-speed inflight connectivity solution and live TV on 70 of the airline's aircraft. 2Ku is the industry's leading inflight connectivity solution and delivers a ground-like internet experience for passengers. The launch of high-speed Wi-Fi will be coupled with live TV to passenger devices as well as seatback screens. The carrier will install 2Ku on its Boeing 787-9, 787-8 and Airbus A380 fleets.

08:04 EST Salesforce, Amazon Web Services expand partnership - Amazon Web Services (AMZN) and Salesforce (CRM) announced an expansion of their global strategic partnership. Salesforce is introducing Service Cloud Voice, a new offering that seamlessly integrates Amazon Connect, to provide contact center agents with a complete set of tools in their agent workspace to deliver enhanced customer service support. Salesforce already relies on AWS as its primary public cloud provider, and through this partnership, Salesforce has chosen Amazon Connect as its preferred contact center technology. As part of its Service Cloud Voice offering, Salesforce will now offer Amazon Connect, a simple to use cloud contact center service from AWS that makes it easy for organizations to deliver better customer service at a lower cost. In addition, Salesforce and AWS are making AWS content available on Trailhead, Salesforce's free online learning platform, to train anyone to become proficient in the cloud. Finally, Salesforce is exploring ways to make Einstein Voice Skills - a declarative platform tool - compatible with Amazon Alexa, among other voice assistants and devices.

08:03 EST AMSC announces $20M D-VAR system orders - AMSC announced $20M of D-VAR STATCOM system orders. Most of the orders pertain to the renewable energy sector in the U.S. followed by a few orders serving the industrial power quality sector. These D-VAR systems are expected to provide voltage regulation by dynamically responding to varying load conditions while connecting wind power plants to the electric grid.

08:03 EST Personalis announces collaboration with Merck KGaA - Personalis (PSNL) announced a collaboration with Merck KGaA, Darmstadt, Germany (MKGAY) to investigate novel biomarkers of response and mechanisms of resistance to cancer therapies. Merck KGaA, Darmstadt, Germany, will utilize Personalis' newest cancer immunogenomics platform, ImmunoID NeXT, for clinical biomarker identification and development.

08:02 EST CNS completes agreement with HPI to obtain rights for Berubicin - CNS Pharmaceuticals completed an agreement with Houston Pharmaceuticals, or HPI, to obtain the rights to a worldwide, exclusive royalty-bearing, license for the chemical compound commonly known as Berubicin. CNS' licensing agreement with HPI grants the Company the exclusive right to develop certain patented chemical compounds for use in the treatment of cancer globally. In its agreement with HPI, the Company acquired multiple U.S. patents for Berubicin. CNS intends to apply for orphan drug status for Berubicin with the FDA for the treatment of malignant glioma.

07:47 EST Scholar Rock announces preliminary PK, PD data from TOPAZ trial of SRK-015 - Scholar Rock announced preliminary pharmacokinetic and pharmacodynamic results from the TOPAZ Phase 2 proof-of-concept trial of SRK-015 for the treatment of patients with spinal muscular atrophy. The planned preliminary PK/PD analysis, which includes data from 29 patients with SMA across all three cohorts, showed dose-proportional drug exposure and demonstrated target engagement, as evidenced by dose-dependent increases of up to 100-fold in the serum levels of latent myostatin following SRK-015 treatment. SRK-015 is a highly selective inhibitor of the precursor, or latent form, of myostatin, and was specifically designed to avoid interactions with related targets such as activins, GDF-11, or BMPs, to potentially improve the therapeutic profile compared to traditional non-selective inhibitors. The Phase 2 proof-of-concept trial is evaluating the safety and efficacy of SRK-015 dosed intravenously every four weeks over a 12-month treatment period. The trial is anticipated to enroll approximately 55 patients with Type 2 or Type 3 SMA in the U.S. and Europe across three distinct cohorts. Patients in Cohorts 1 and 2 are being treated with 20 mg/kg of SRK-015 Q4W and patients in Cohort 3 are randomized to either 20 mg/kg or 2 mg/kg Q4W. The primary objectives of the cohorts are to assess safety and clinically meaningful motor functional outcomes, such as the Revised Hammersmith Scale and the Hammersmith Functional Motor Scale Expanded. The preliminary PK/PD analysis of the TOPAZ trial includes data from 29 patients across the three cohorts; 12 patients in Cohort 1, eight patients in Cohort 2, and nine patients in Cohort 3. These patients had received one dose of SRK-015 and were evaluated for four weeks as of the data cutoff. The preliminary results are as follows: Dose-dependent increases of up to 100-fold in serum latent myostatin levels following treatment with SRK-015 confirms the presence of latent myostatin in patients with SMA and demonstrates robust target engagement. Fold-increases from baseline in serum latent myostatin levels in the first four weeks following SRK-015 treatment were comparable between SMA patients in the TOPAZ trial and healthy adult volunteers in the Phase 1 trial. In patients with SMA, SRK-015 displayed a preliminary PK profile exhibiting dose proportionality and low variability, consistent with PK observations from the Phase 1 trial in healthy adult volunteers. No clinically significant safety signals had been observed as of the data cutoff for this preliminary PK/PD analysis. An interim efficacy and safety analysis is planned, encompassing a subset of patients with at least six months of treatment exposure. The interim results are expected in the first half of 2020 with top-line results for the full 12-month treatment period expected starting in the fourth quarter of 2020 and through the first quarter of 2021.

07:44 EST Achillion granted EMA PRIME designation for danicopan for PNH treatment - Achillion Pharmaceuticals announced that the European Medicines Agency has granted access to support through the PRIME program for danicopan in the treatment of paroxysmal nocturnal hemoglobinuria in patients who are not adequately responding to a C5 inhibitor. The decision from the EMA was based on danicopan safety and efficacy data from the Phase 2 PNH combination trial. The top-line 24-week results from this combination trial was accepted for poster presentation at the 61st American Society of Hematology Annual Meeting scheduled for December 9th in Orlando, FL.

07:41 EST OpGen says products in development to address 'urgent threat' pathogens - OpGen announced that the Center for Disease Control has released updated data increasing the number of deaths in the United States from antibiotic-resistant bacteria and fungi, and highlighting the continuing threat of rising antibiotic resistance. According to the CDC, these pathogens cause more than 2.8 million infections and 35,000 deaths in the U.S. each year. That means, on average, someone in the United States gets an antibiotic-resistant infection every 11 seconds, and every 15 minutes, someone dies. OpGen's products have been developed to help combat these growing threats. The Acuitas AMR Gene Panel test, currently in development, is designed to help identify drug-resistant pathogens directly from urine as an aid in the diagnosis of urinary tract infections in under three hours. The Acuitas Lighthouse Software, also in development, is currently being tested in a state-wide initiative to help quickly identify and track urgent threat pathogens. The Acuitas AMR Gene Panel test is being developed for patients at risk for complicated urinary tract infections and is designed to test for up to five pathogens and up to 47 antimicrobial genes. When paired with the Acuitas Lighthouse Software, OpGen believes the test will be able to help improve management of the more than one million patients in the United States with cUTI. Specifically, the Acuitas AMR Gene Panel test, in combination with the Acuitas Lighthouse Software, both in development, can help test for and identify major concerns for hospital patients, including Carbapenem-Resistant Enterobacteriaceae, Multidrug-Resistant Pseudomonas Aeruginosa, and Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae. OpGen is conducting clinical trials in 2019 to support a submission for the direct-from-urine Acuitas AMR Gene Panel test and for the Acuitas Lighthouse Software for antibiotic resistance prediction for the management of antimicrobial resistance data in healthcare institutions. Earlier this year, clinical trials were conducted for establishing the performance of the Acuitas AMR Gene Panel for use with bacterial isolates. Data obtained from the clinical trials were submitted in a 510(k) submission which is currently under review by the U.S. Food and Drug Administration.

07:37 EST Affimed N.V. expects cash, cash equivalents to fund operations into 4Q21 - Cash, cash equivalents and current financial assets totaled EUR76.5M as of September 30, 2019, compared to EUR108.8M as of December 31, 2018. In November 2019, Affimed completed a public equity offering with net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, of approximately $32M. Based on its current operating and budget assumptions, the company anticipates that its cash, cash equivalents and current financial assets as of September 30, 2019, together with the proceeds from the stock offering, will enable the Company to fund its planned clinical development and early development activities at least into the fourth quarter of 2021.

07:35 EST Affimed N.V. plans preclinical studies for AFM28, AFM32 in 2020 - Affimed selected two new CD16A-binding innate cell engager candidates from our ROCK platform for undisclosed targets that the company plans to advance into preclinical studies in 2020 with the aim of supporting future IND submissions. The selection of the new development candidates follows Affimed's evaluation of innate immune cell activity versus a number of potential targets that are expressed in multiple hematological and solid tumor malignancies.

07:32 EST Moleculin Biotech reports preliminary data from clinical trial of WP1220 - Moleculin Biotech announced it now has preliminary data from its clinical trial of WP1220 for the treatment of cutaneous T-cell lymphoma, which was published in Blood in conjunction with the American Society of Hematology Annual Meeting and Exposition to be held December 7-10. "For years, p-STAT3 has been considered an 'undruggable' target because of the difficulty of reaching and affecting this cell-signaling protein," commented Moleculin biotech. "Some consider it to be a master regulator of cancer-related gene transcription, so we believe the ability to show a therapeutic effect from a p-STAT3 inhibitor could be considered a significant breakthrough in cancer research." There were 6 patients screened, and 5 patients enrolled between March and July. Three are evaluable for both safety and efficacy after completing 3 months of treatment, with 2 ongoing and evaluable for safety. The only AE reported potentially related to study drug in one of the five patients was a mild contact dermatitis not requiring treatment. In summary, according to the company, WP1220, an inhibitor of p-STAT3, has shown demonstrable safety and significant efficacy after at least 3 months of topical treatment in 3 patients with progressive MF, with a continuing trend towards improvement in additional patients currently in treatment.

07:27 EST CURE Pharmaceutical appoints John Bell to board of directors - CURE Pharmaceutical (CURR) announced that it has named John Bell to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers (CNPOF) board of directors and former chairman of Canopy Growth's (CGC) board of directors.

07:24 EST U.S. Federal Transit Administration selects Hill International for PMO services - Hill International announced that it has been selected by the U.S. Federal Transit Administration to continue providing project management oversight services on major transit capital projects nationwide. The five-year IDIQ contract has an estimated anticipated dollar value for Hill and its subcontractors of no more than $35M.

07:20 EST Yamana Gold announces exploration results for Cerro Moro mine - YAMANA GOLD announced exploration results for the Cerro Moro mine in Argentina, all of which show significant high-grade intersections in an entirely new zone and extensions of previously identified zones. These exploration results demonstrate a growing mineral resource base in new areas that are expected to establish Cerro Moro as a long-life, high-quality, high-grade gold and silver operation. Exploration Highlights: Discovery of a new mineralized zone. Drill intercepts are helping to define a significant new mineralized zone along the Naty structure, located 25 kilometres south of the core mine. Significant results from new exploration drilling in core mine area. High-grade intercepts in the Nini Extension, Tres Lomas, Michelle, and Deborah sectors. Encountering high grades in the Martina and Escondida sectors. Select drill intercepts exceed 100 grams per tonne of gold. Exploration program extended to entire Cerro Moro concession. Program now covers the full 150,000-hectare land package. The Company has committed to an initial four-year exploration program, which began in early 2018, to systematically explore Cerro Moro. The program combines soil and rock geochemistry, ground geophysics, surface geological and alteration mapping, and reconnaissance drilling. Through the third quarter of 2019, more than 9,700 soil samples and 5,300 rock samples have been analyzed, 76 line kilometres of CSAMT surveys have been completed, and 23,400 metres of reconnaissance RC and diamond drilling have been completed. The program has led to the discovery of new mineralization in several areas of the property with positive results in the core mine as well as the newly discovered Naty zone. It has also extended historically known veins not currently in the mine plan, generating new targets for additional mineral resources.

07:19 EST Aleafia's FoliEdge Academy enters agreement with post-secondary institution - Aleafia Health's wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with a Canadian post-secondary institution to introduce cannabis education courses and programs. The partner institution announcement and courses launch will occur later this year. FoliEdge Academy is an interactive cannabis education and certification platform, featuring proprietary, interactive courses customized for large organizations. In return for the courses, the institution will pay license fees to FoliEdge. The courses will be offered to students of the institution on a non-exclusive basis for a one-year term which is automatically renewable for two consecutive one year terms unless notice is provided at least 90 days before the commencement of the renewal term.

07:17 EST Yamana Gold commences drill program at Organullo Gold Project - Latin Metals provides an update on the Organullo Property, located in Salta Province, Argentina. The Organullo Property is 100% owned by Latin Metals. Yamana Gold, through a subsidiary, has been granted an option to acquire an initial 70% interest in the Property. During 2019, Yamana funded an extensive mapping, rock sampling and soil sampling program establishing geochemical anomalies over a strike length of approximately 8km. A diamond drill program has commenced on the Property and Yamana plans to complete approximately 3,300m of diamond drilling for a total of 16 exploration drill holes.

07:11 EST Crispr, Vertex announce interim data from first two patients treated with CTX001 - CRISPR Therapeutics (CRSP) and Vertex Pharmaceuticals Incorporated (VRTX) announced positive, interim data from the first two patients with severe hemoglobinopathies treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001 in ongoing Phase 1/2 clinical trials. One patient with transfusion-dependent beta thalassemia received CTX001 in the first quarter of 2019 and data for this patient reflect nine months of safety and efficacy follow-up. One patient with severe sickle cell disease received CTX001 in mid-2019 and data for this patient reflect four months of safety and efficacy follow-up. These studies are ongoing and patients will be followed for approximately two years following infusion. Several additional patients have been enrolled and have had drug product manufactured across the two studies. The patient with TDT has the beta0/IVS-I-110 genotype and required 16.5 transfusions per year before enrolling in the clinical study. The patient achieved neutrophil engraftment 33 days after CTX001 infusion and platelet engraftment 37 days after infusion. Two serious adverse events occurred, neither of which the principal investigator considered related to CTX001: pneumonia in the presence of neutropenia and veno-occlusive liver disease attributed to busulfan conditioning; both subsequently resolved. At nine months after CTX001 infusion, the patient was transfusion independent and had total hemoglobin levels of 11.9 g/dL, 10.1 g/dL fetal hemoglobin, and 99.8% F-cells. The patient with SCD experienced seven vaso-occlusive crises per year before enrolling in the clinical study. The patient achieved neutrophil and platelet engraftment 30 days after CTX001 infusion. Three SAEs occurred, none of which the PI considered related to CTX001: sepsis in the presence of neutropenia, cholelithiasis, and abdominal pain, all of which resolved. At four months after CTX001 infusion, the patient was free of VOCs and had total hemoglobin levels of 11.3 g/dL, 46.6% fetal hemoglobin, and 94.7% F-cells.

07:08 EST RedHill Biopharma to complete enrollment for Yeliva study in 'coming months' - The ongoing Phase 2a study evaluating the activity of orally-administered ABC294640 in advanced cholangiocarcinoma continues to enroll patients in the second stage of the two-stage study design. Enrollment of the full cohort of 39 evaluable patients is expected to be completed in the coming months. An investigator-sponsored study with ABC294640 in prostate cancer is planned to be initiated at the Medical University of South Carolina by early 2020. The study is supported by a National Cancer Institute grant awarded to MUSC.

07:07 EST RedHill Biopharma 'working toward' confirmatory Phase 3 study for BEKINDA - RedHill concluded a positive FDA meeting on the pediatric study plans required to potentially obtain pediatric labeling for RHB-102 in addition to the intended adult labeling. RedHill is currently working toward a confirmatory Phase 3 study to support a potential NDA for RHB-102 for acute gastroenteritis and gastritis, subject to FDA guidance. The confirmatory Phase 3 study will follow the successful completion of a first Phase 3 study with RHB-102 for acute gastroenteritis and gastritis, the results of which were recently published in JAMA Open Networks.

07:06 EST Viking Therapeutics begins Phase 2b clinical trial of VK2809 - Viking Therapeutics announced the initiation of a Phase 2b clinical trial of VK2809, its novel liver-selective thyroid hormone receptor beta agonist, in patients with biopsy-confirmed non-alcoholic steatohepatitis, or NASH. Clinical trial sites are open for patient enrollment following clearance of the company's Investigational New Drug, or IND, application by the FDA. The VOYAGE study is a randomized, double-blind, placebo-controlled, multicenter trial designed to assess the efficacy, safety and tolerability of VK2809 in patients with biopsy-confirmed NASH and fibrosis ranging from stages F1 to F3. Patients with certain comorbid conditions such as type 2 diabetes, as well as patients receiving certain lipid-lowing medications, including statins, are eligible for enrollment.

07:05 EST RedHill Biopharma expects to launch Aemcolo in the U.S. during 4Q19

07:02 EST Shutterstock launches unlimited monthly subscription for music - Shutterstock announced the launch of an unlimited monthly subscription for Shutterstock Music. The new plan is geared toward digital content creators, including YouTubers, podcast producers, and social media managers, offering a cost-efficient solution to licensing unlimited high-quality tracks at $149 per month. Additionally, to meet the needs of short-form content projects, Shutterstock Music now offers shorter tracks for all license plans

07:01 EST CN appoints Rob Really as interim Chief Information and Technology Officer - CN announced that Michael Foster, executive vice-president and Chief Information and Technology Officer is leaving the company on November 29. Michael is leaving for personal reasons, moving back to the U.S., to be close to where his family is located and to pursue other career opportunities. CN has announced that Rob Reilly, executive vice-president and Chief Operating Officer, will assume interim responsibility for the company's Information and Technology function, while the company carries out a global search for a chief information and technology officer. Rob gained extensive leadership and innovation experience in rail operations and field application of rail technologies at another Class I railway, making him the right executive to lead the company's information and technology group during this transition. He will continue to deliver on operational excellence and the implementation of advanced information technologies as a driver for safety, customer and shareholder value and the company's strategy to enhance its scheduled railroading model.

06:48 EST Medtronic CEO says 'we're even more excited about what lies ahead' - "We reported another quarter of solid results, reflecting our continued focus on executing to our commitments across Medtronic," said Omar Ishrak, Medtronic chairman and CEO. "Our broad-based performance this quarter demonstrates the consistency of our execution, the strength of our innovation, and the benefit of our business and geographic diversification. The first half of this fiscal year has gone well, as we've executed to our commitments and delivered better-than-expected results. As we look forward, we're even more excited about what lies ahead, as the investments we've made in our pipeline begin to pay off by accelerating our revenue growth and creating value for our shareholders."

06:38 EST Boeing announces service orders, agreements at the Dubai Airshow - Boeing (BA) announced at the Dubai Airshow services orders and agreements with airlines and governments to provide lifecycle value to their fleets and enable connectivity, exploration and mission readiness. The Middle East is one of the fastest growing aviation services markets in the world, with Boeing forecasting a combined addressable market in the region for commercial and defense services worth $225B over the next 10 years. Egypt signed an Apache Sustainment Extension for technical assistance and on-site support. FlySAFAIR joins more than 300 international customers using Boeing maintenance performance toolbox to access their fleets' real-time digital maintenance data and engineering, and certification information. Kuwait finalized an agreement for integrated logistics support, or ILS, which provides F/A-18 support equipment, aircrew courseware and training devices, and technical publications. Saudi National Center of Aviation signed an agreement with Boeing for its Jeppesen dispatcher training. This agreement provides Jeppesen training content, including electronic training materials, and instructors to train SNCA students throughout the Middle East as part of its dispatch curriculum. TAAG Angola Airlines reached a five-year agreement for Boeing Global Services' global fleet care. This agreement provides virtual maintenance and engineering support for TAAG's entire fleet of 15 Boeing 777 and 737-700 aircraft. Boeing previously announced at the Dubai Airshow agreements with EGYPTAIR, Ethiopian Airlines, Etihad Airways and Saudi Arabian Airlines for a range of aircraft lifecycle solutions spanning global services' suite of offerings, including landing gear, engine support, digital solutions, and materials parts access. Korea signed a multiyear F-15K F110 engines spares agreement that will provide spares for the Republic of Korea's fleet of F-15 aircraft. India reached a three-year training renewal agreement for C-17 training services for the Indian Air Force. Latam Airlines (LTM) announced multiyear agreements that will provide Latam access to Boeing's global supply chain for 787 and 777 landing gear exchange services. Japan signed a foreign military sale agreement for ILS for the country's V-22 fleet. Norwegian Air Shuttle has reached a multiyear agreement for Jeppesen FliteDeck Pro electronic flight bag solution, including NavData digital navigation services, airport data, and required navigation performance services. Netherlands and Boeing continue to work together to support the Royal Netherlands Air Force's AH-64E helicopters in line with the U.S. Government and the newest capabilities.

06:22 EST CytoDyn: Leronlimab inhibits colon carcinoma metastases to liver, lung in study - CytoDyn announced that leronlimab inhibited a human colon carcinoma cell line, SW480 cells, metastases to liver and lung in a well-accepted mouse model. These human colon carcinoma cells were implanted in the colon walls of immunodeficient mice and treated with a control antibody or leronlimab. After four weeks, the mice were sacrificed and the lungs and livers removed for analysis of invasion of the colon cancer cells. Leronlimab produced statistically significant inhibition of metastases to lung and liver in this mouse model.

06:10 EST Boeing says Ghana intends to relaunch airline with three 787-9 Dreamliners - Boeing and the Republic of Ghana announced that the country intends to relaunch an airline starting with the 787-9 Dreamliner. The parties signed a memorandum of understanding at the Dubai Air Show for three airplanes with a list price value of $877.5M according to list prices. The 787-9 is part of a family of three airplanes that offer long ranges and fuel efficiency in the 200 to 350 seat market. The 787-9 can carry 296 passengers and fly up to 7,530 nautical miles, while reducing fuel use and emissions by 20%-25% compared to older airplanes.

06:06 EST KLX Energy to reduce force by 17% and take a Q3 charge of $13M - KLX Energy Services Holdings announced a major cost reduction program to address the abrupt deterioration in industry conditions, which accelerated downward through the end of the Q3. Amin J. Khoury, CEO of KLX Energy Services commented, "Contemporaneously with the abrupt decline in activity, we took steps to align our business with current customer demand. Specifically, we implemented an approximate 17% reduction in force, as compared with the Company's July 31 staffing levels, consistent with the approximate 18% sequential quarterly decline in our Q3 revenues. We aggressively cut costs in every area of our business, and we warm stacked the vast majority of our Permian based wireline assets. As a result of these and other measures, we expect to take a Q3 charge of approximately $13M."

06:05 EST Home Depot down 6.7% after reporting Q3 results, cutting FY19 revenue guidance

05:46 EST Google acquires cloud partner CloudSimple, terms not disclosed - Google (GOOGL) announced in a blog post that it has acquired CloudSimple, "a leading provider of secure, high performance, dedicated environments to run VMware (VMW) workloads in the cloud." Google VP Engineering Rich Sanzi says: "This acquisition builds on our existing partnership with CloudSimple that we announced earlier this year, allowing us to accelerate a fully integrated VMware migration solution with improved support for our customers." "We look forward to continuing our partnership with Google Cloud as they welcome CloudSimple, a VMware Cloud Verified partner," said Ajay Patel, senior vice president, Cloud Provider Software Unit at VMware. Reference Link

05:40 EST JinkoSolar sees FY19 solar module shipments 18 GW to 20.0 GW - JinkoSolar expects its annual silicon wafer, solar cell and solar module production capacity to reach 20.0 GW (including 18.0 GW of mono wafers), 10.6 GW (including 800 MW N-type cells) and 22.0 GW, respectively, by the end of 2020.

05:20 EST Turquoise Hill notes Administrative Court proceedings in Mongolia - Turquoise Hill Resources notes Administrative Court proceedings in Mongolia with regard to a lawsuit initiated by the Darkhan Mongol Nogoon Negdel Non-Governmental Organization, or NGO, relating to the Government of Mongolia's process in finalising the Oyu Tolgoi Underground Mine Development and Financing Plan, or UDP. Early reports suggest the Administrative Court of first instance has upheld claims by the NGO that due process was not followed by the Government of Mongolia in finalising the UDP, although the Court's formal written ruling is expected to be released only in the coming weeks. TRQ strongly refutes any suggestion that the UDP or any of the foundational OT Agreements are illegal. Adherence to the principles of the Investment Agreement, ARSHA and the Underground Plan has allowed for the development of the Oyu Tolgoi mine in a manner that has given rise to significant long-term benefits to the people of Mongolia.

05:15 EST BlackBerry QNX technology to power Arrival intelligent, autonomous-ready EVs - BlackBerry and electric vehicle company Arrival announced that Arrival's intelligent, autonomous-ready commercial vehicles will be powered by BlackBerry QNX technology. As part of the agreement, BlackBerry will license its BlackBerry QNX technology to Arrival, including its industry-leading QNX SDP 7.0 real-time operating system to serve as the safe and secure foundation for the ADAS features within the company's autonomous-ready commercial vehicle platform.

05:07 EST ExOne announces collaboration with Ansys - ExOne (XONE) and ANSYS (ANSS) have entered into a collaboration to develop software that predicts the sintering behavior of binder jetted metal parts. A beta software release for 316L stainless steel is targeted for the first quarter of 2020, with modeling software for other materials expected to follow.